Here, we identify a HES1‐YAP1‐CDKN1C functional interaction that is present in human FN‐RMS cell lines and tumor tissue, and show that by blocking HES1 activity via genetic or pharmacologic approaches, we can interfere with FN‐RMS cell growth in vitro and tumorigenesis in vivo. Here, CDKN1C is linked to neoplasm.